Medicare Enrolled

Dr. Ronald Levy, MD

Gastroenterology · Lake Worth, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
6944 LAKE WORTH RD, Lake Worth, FL 33467
5614340060
In practice since 2005 (20 years)
NPI: 1558350975 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Levy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Levy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Levy

Dr. Ronald Levy is a gastroenterology specialist in Lake Worth, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Levy performed 16,969 Medicare services across 904 unique beneficiaries.

Between the years covered by Open Payments, Dr. Levy received a total of $6,567 from 51 pharmaceutical and/or device companies across 355 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Levy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 1% volume in FL $6,567 industry payments

Medicare Practice Summary

Medicare Utilization ↗
16,969
Medicare services
Top 1% in FL for gastroenterology
904
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~848 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Vedolizumab infusion (Entyvio) 14,100 $17 $52
Infliximab infusion (Remicade) 1,640 $26 $231
Office visit, established patient (20-29 min) 559 $65 $237
Upper GI endoscopy with biopsy 92 $73 $1,181
New patient office visit (45-59 min) 83 $132 $542
Removal of polyps or growths of large bowel using an endoscope with mechanical snare 82 $225 $1,426
Office visit, established patient (30-39 min) 76 $94 $348
Hospital follow-up visit, moderate complexity 64 $65 $237
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 60 $52 $223
Initial hospital admission, high complexity 57 $145 $670
Colonoscopy with biopsy 53 $94 $1,497
Administration of chemotherapy into vein, 1 hour or less 33 $107 $1,000
New patient office visit (30-44 min) 32 $88 $358
Hospital follow-up visit, high complexity 21 $99 $344
Colorectal cancer screening; colonoscopy on individual at high risk 17 $195 $1,130
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
93.1% high complexity
1.1% medium
5.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$6,567
Total received (2018-2024)
Avg $938/year across 7 years
Top 27% in FL for gastroenterology
51
Companies
355
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,945 (90.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$622 (9.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,345
2023
$920
2022
$1,028
2021
$935
2020
$447
2019
$994
2018
$899

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$753
ABBVIE INC.
$613
Janssen Biotech, Inc.
$520
AbbVie, Inc.
$463
AbbVie Inc.
$458
Celgene Corporation
$431
E.R. Squibb & Sons, L.L.C.
$246
Merck Sharp & Dohme LLC
$237
Allergan Inc.
$225
Gilead Sciences, Inc.
$219
Lilly USA, LLC
$217
Braintree Laboratories, Inc.
$216
Synergy Pharmaceuticals Inc
$183
Intercept Pharmaceuticals, Inc.
$160
Takeda Pharmaceuticals U.S.A., Inc.
$136
Celltrion USA Inc.
$125
PFIZER INC.
$117
RedHill Biopharma Inc.
$114
Ardelyx, Inc.
$103
GENZYME CORPORATION
$85
UCB, Inc.
$68
Daiichi Sankyo Inc.
$66
ERBE USA INC
$65
QOL Medical, LLC
$64
Ferring Pharmaceuticals Inc.
$58
Regeneron Healthcare Solutions, Inc.
$52
Merck Sharp & Dohme Corporation
$52
INTERCEPT PHARMACEUTICALS, INC.
$49
Madrigal Pharmaceuticals
$49
Alexion Pharmaceuticals, Inc.
$29
Ipsen Biopharmaceuticals, Inc
$24
Ethicon US, LLC
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
Micro-tech Endoscopy USA, Inc.
$22
Echosens North America, Inc.
$22
Teva Pharmaceuticals USA, Inc.
$21
Concordia Pharmaceuticals Inc.
$20
Exact Sciences Corporation
$20
Endo Pharmaceuticals Inc.
$20
Sebela Pharmaceuticals Inc.
$20
NESTLE HEALTHCARE NUTRITION INC.
$19
FUJIFILM Healthcare Americas Corporation
$19
Eagle Pharmaceuticals, Inc.
$19
CSL Behring
$19
Evoke Pharma, Inc.
$16
Romark Laboratories, LC
$16
IRONWOOD PHARMACEUTICALS, INC
$15
Shire North American Group Inc
$15
Allergan, Inc.
$14
Nestle HealthCare Nutrition Inc.
$13
Boston Scientific Corporation
$13
Top 3 companies account for 28.7% of total payments
Associated products mentioned in payments ›
ANALPRAM · APRISO · Aemcolo · Alinia Tablets 500mg 30 count bottle · Bylvay · CLENPIQ · CREON · CYLTEZO · Cimzia · Cologuard Collection Kit · Creon · DAT Device · DIFICID · DONNATAL · DUPIXENT · ENTYVIO · FUJIFILM · Fibroscan · GATTEX · GIMOTI · General - Pain Management · HUMIRA · Haegarda · Humira · IBSRELA · INJECTAFER · Kanuma · LINZESS · Linzess · MAVYRET · MOTOFEN · Mavyret · Movantik · NASCOBAL · OCALIVA · OMVOH · PLENVU · REMICADE · RESMETIROM · RINVOQ · Ryanodex · SIMLANDI · SKYRIZI · STELARA · SUPREP BOWEL PREP · SUTAB · Sucraid · TREMFYA · Talicia · Trulance · UCERIS TABLETS · VEGZELMA · VELSIPITY · VIBERZI · Vio3 · XELJANZ · XIFAXAN · XIFAXANIBSD · YUFLYMA · ZENPEP · ZEPOSIA · ZYMFENTRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $39 per 100 Medicare services performed
Looking for a gastroenterology specialist in Lake Worth?
Compare gastroenterologists in the Lake Worth area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
122
Per 100K population
8.1
County median income
$81,115
Nearest hospital
WELLINGTON REGIONAL MEDICAL CENTER
5.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Levy is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Levy experienced with vedolizumab infusion (entyvio)?
Based on Medicare claims data, Dr. Levy performed 14,100 vedolizumab infusion (entyvio) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Levy receive payments from pharmaceutical companies?
Yes. Dr. Levy received a total of $6,567 from 51 companies across 355 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Levy's costs compare to other gastroenterologists in Lake Worth?
Dr. Levy's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Levy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →